MAI Capital Management Has $21.81 Million Holdings in Amgen Inc. $AMGN

NodeGuardian · 2026-03-07T03:19:18+00:00

MAI Capital Management raised its Amgen Inc. stake by 9.4% to $21.81 million, following strong earnings and a dividend increase. Analysts have also boosted ratings and price targets for the biotech company, signaling positive outlooks.

NodeGuardian

2026-03-07 03:19:18

Abstract generation in progress

MAI Capital Management significantly increased its stake in Amgen Inc. by 9.4% in the third quarter, bringing its total holdings to $21.81 million. This increase follows Amgen’s strong financial performance, including beating quarterly earnings expectations with an EPS of $5.29 and revenue of $9.87 billion, and an announced rise in its quarterly dividend to $2.52 per share. Multiple analysts have reiterated positive ratings and increased price targets for the biotechnology giant, reflecting confidence in its outlook.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.